TRACON Pharmaceuticals Inc

NASDAQ:TCON   3:59:48 PM EDT
10.04
+1.20 (+13.65%)
Earnings Announcements

Tracon Pharmaceuticals Reports Third Quarter 2020 Financial Results And Provides Corporate Update

Published: 11/10/2020 21:34 GMT
TRACON Pharmaceuticals Inc (TCON) - Tracon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update.
Tracon Pharmaceuticals Inc Qtrly Loss per Share $0.38.
Tracon Pharmaceuticals Inc - Cash and Cash Equivalents Were $26.5 Million at September 30, 2020.
Tracon Pharmaceuticals Inc - Expect Our Current Cash and Cash Equivalents to Fund Operations Into Q1 of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.32

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.